pharma news today glp-1 obesity drug What is the pipeline for future medications for obesity? pharma news today glp-1 2025

BPC-157 is a synthetic 15-amino-acid peptide fragment originally isolated from human gastric juice, where it occurs as part of a larger body-protective protein

Supplementation of maturation medium with CoQ10 enhances developmental competence of ovine oocytes through improvement of mitochondrial function

Wyatt suggests forming a morning ritual that encompasses gratitude, excitement or intention, such as affirmations or visualizations

Sasson, A

A review of head-to-head clinical trials comparing key outcomes of using GLP-1RAs (dulaglutide, exenatide BD, exenatide QW, liraglutide or lixisenatide) with those of using DPP-IV (sitagliptin), SU (glimepiride

moderate-to-severe obstructive sleep apnea (OSA) and obesity to improve their OSA